Chinese biopharmaceutical startup Sinovent has raised 1 billion yuan ($145 million) in a Series C round of financing co-led by Loyal Valley Innovation Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
